Emergent Biosolutions EBS EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
Based on trailing twelve months.
The official record: Emergent Biosolutions’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's EBITDA margin?
- Emergent Biosolutions (EBS) reported EBITDA margin of 27.5% in Q3 2025.
- How has Emergent Biosolutions's EBITDA margin changed year-over-year?
- Emergent Biosolutions's EBITDA margin increased by 1110.8% year-over-year, from -2.7% to 27.5%.
- What is the long-term trend for Emergent Biosolutions's EBITDA margin?
- Over 4 years (2020 to 2024), Emergent Biosolutions's EBITDA margin has grown at a -87.2% compound annual growth rate (CAGR), from 36.2% to 0%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.